Congressman Greg Murphy, M.D., has been vocal on social media about several pressing issues in the healthcare and medical education sectors. Through a series of tweets, he addresses concerns ranging from drug pricing to educational standards and legislative developments.
On May 12, 2025, Congressman Murphy highlighted his stance on drug pricing by pointing out that “Going after high drug costs means going after PBM’s owned by insurance companies. THEY are the real cause of high drug prices.” This statement underscores his belief that pharmacy benefit managers (PBMs), particularly those affiliated with insurance companies, play a significant role in driving up medication costs.
Later that day, Murphy expressed criticism towards UCLA’s medical degree program. He stated that “No longer does a medical degree from @UCLA represent excellence. They discriminate against immutable characteristics and merit.” He further criticized the leadership in medical education for allegedly not prioritizing having “the brightest and hardest working doctors.”
On May 13, 2025, Congressman Murphy conveyed disappointment regarding legislative matters affecting medical research. He noted that “Am extremely disappointed that the EPIC Act is no longer in the House bill.” According to him, this exclusion is problematic because the Inflation Reduction Act’s ‘Pill Penalty’ has led to the cessation of over 180 drug trials which could have resulted in new cures.
The EPIC Act refers to proposed legislation aimed at enhancing pharmaceutical innovation through collaboration. The IRA’s ‘Pill Penalty’ mentioned by Murphy refers to provisions within the Inflation Reduction Act perceived as discouraging investment in pharmaceutical research.
